Silex Systems (SLX) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
Meeting opened with confirmation of quorum, virtual participation options, and prior minutes tabled for inspection.
CEO Dr Michael Goldsworthy led the 2024 AGM, outlining the mission to commercialise SILEX laser enrichment technology for uranium, silicon, and medical isotopes.
Board members, including a new director candidate, and audit partner introduced; agenda included business updates and voting instructions.
Shareholders could submit questions in advance or live, with moderation to ensure efficiency.
Voting on all items conducted via poll, with both in-person and online mechanisms explained.
Financial performance review
As of 30 June 2024, cash and term deposit holdings were $113.1m with no corporate debt.
Over $2 million in license revenue reported, including royalties from technology agreements.
Cash burn for the previous year was discussed, with expectations of a slight increase for the next year due to ongoing projects.
Company remains well-capitalized, with a positive outlook on funding.
Board and executive committee updates
Susie Corlett introduced as a new board candidate, bringing extensive mining, finance, and governance experience.
Helen Cook retired from the board, recognized for her significant contributions.
Board maintains active assessment programs to ensure governance and competency breadth.
Latest events from Silex Systems
- GLE's SILEX technology targets US nuclear fuel independence with strong market and policy tailwinds.SLX
Investor presentation24 Feb 2026 - Revenue doubled and cash surged after a capital raise; GLE secured a major U.S. DOE award.SLX
H1 202624 Feb 2026 - Robust financials and tech milestones drive strategic growth in nuclear and silicon sectors.SLX
AGM 20253 Feb 2026 - Major technology milestone and US support position SILEX for uranium and quantum silicon growth.SLX
Investor Presentation9 Nov 2025 - Net loss widened to $42.6m as SILEX technology nears commercial readiness; strong cash raised.SLX
H2 202526 Aug 2025 - $145m equity raise funds SILEX laser enrichment commercialisation, targeting US nuclear fuel supply.SLX
Investor Presentation7 Aug 2025 - GLE's SILEX technology is on track for commercialisation, targeting major US nuclear fuel supply gaps.SLX
Investor Presentation30 Jun 2025 - GLE pilot and Silex's diversification position the company for growth amid nuclear market shifts.SLX
H2 202413 Jun 2025 - GLE accelerates SILEX technology for uranium, silicon, and isotope markets, targeting 2028 launch.SLX
Investor Presentation13 Jun 2025